Navigation Links
WuXi PharmaTech Announces Second Quarter 2011 Results
Date:8/10/2011

2288;

-

2,933

(100.0%)Amortization of acquired intangible assets

 

355

764

(53.5%)

 

710

1,528

(53.5%)Deferred tax impact related to acquired intangible assets

 

(137)

(296)

(53.7%)

 

(275)

(592)

(53.5%)Non-GAAP net income 

21,978

19,907

10.4%

 

43,356

38,214

13.5%Non-GAAP net margin 

21.7%

24.6%

 

 

22.3%

23.6%

 Income attributable to holders of ADS (Non-GAAP): 

 

 

 

 

 

 

 Basic 

21,978

19,907

10.4%

 

43,356

38,214

13.5%Diluted 

21,978

19,907

10.4%

 

43,356

38,214

13.5%  

 

 

 

 

 

 

 Basic earnings per ADS (Non-GAAP) 

0.31

0.29

8.2%

 

0.61

0.55

11.4%Diluted earnings per ADS (Non-GAAP) 

0.29

0.27

9.3%

 

0.58

0.51

12.1%  

 

 

 

 

 

 

 Weighted average ADS outstanding– basic (Non-GAAP) 

70,859,356

69,416,476

 

 

70,516,975

69,246,669

 Weighted average ADS outstanding – diluted (Non-GAAP) 

75,329,493

74,591,847

 

 

75,373,691

74,465,668

 WUXI PHARMATECH (CAYMAN) INC.REVENUE BREAKDOWN
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting
2. WuXi PharmaTech Schedules Second-Quarter 2011 Earnings Release
3. WuXi PharmaTech Announces First-Quarter 2011 Results
4. WuXi PharmaTech Files 2010 Annual Report on Form 20-F
5. WuXi PharmaTech Schedules First-Quarter 2011 Earnings Release
6. Bristol-Myers Squibb and WuXi PharmaTech Announce Collaboration for a New Analytical and Stability Testing Facility
7. WuXi PharmaTech Schedules Fourth-Quarter 2010 Earnings Release
8. WuXi PharmaTech Provides Update of 2010 Financial Guidance, to Present at J.P. Morgan Healthcare Conference
9. WuXi PharmaTech Presents 2010 Life Science and Chemistry Awards
10. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2010 Annual General Meeting
11. WuXi PharmaTech Announces Third-Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... , July 30, 2014  Regeneron Pharmaceuticals, Inc. ... and NYSE: SNY ) today announced that ... people with hypercholesterolemia met their primary efficacy endpoint of ... cholesterol (LDL-C) at 24 weeks compared to placebo or ... PCSK9 (proprotein convertase subtilisin/kexin type 9). In ...
(Date:7/30/2014)... SAN DIEGO , July 30, 2014  Eisai ... announced today that an article based on post-hoc analyses from ... Weight Loss While on Lorcaserin, Diet, and Exercise as a ... the online issue of Obesity , the official peer ... analyses was to identify whether there is an early treatment ...
(Date:7/30/2014)... 2014  Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), ... its expertise in opioid antagonists, announced today that ... prominent international research and development foundation. ... research-based initiatives, including those addressing health issues. Lightlake ... delivery of naloxone that could widely expand its ...
Breaking Medicine Technology:Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 4Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 5Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 6Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 7Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation 2Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation 3
... April 29 Wellcore Corporation, a Silicon Valley-based ... safety, begins shipping its highly anticipated Wellcore system today. ... live more active, independent lives, the Wellcore system offers ... will work outside of the home, unlike other fall ...
... on pharma industry , , , ... two whistleblower lawsuits that is being settled as part of Ortho-McNeil-Janssen Pharmaceuticals Inc.,s and Ortho-McNeil Pharmaceutical LLC,s ... northern Virginia . , , , ... , , ...
Cached Medicine Technology:The Wellcore System Begins Shipping Featuring the Most Advanced Automatic Fall Detection Available 2The Wellcore System Begins Shipping Featuring the Most Advanced Automatic Fall Detection Available 3Whistleblower Doctor Comments on His Case that Helped Expose Illegal Marketing of Topamax 2Whistleblower Doctor Comments on His Case that Helped Expose Illegal Marketing of Topamax 3Whistleblower Doctor Comments on His Case that Helped Expose Illegal Marketing of Topamax 4
(Date:7/30/2014)... news of an Ohio teen who died of a ... the normally well-tolerated and mass-consumed substance. To help prevent ... much caffeine, scientists are reporting progress toward a rapid, ... stimulant in most beverages and even breast milk. Their ... Food Chemistry . , Mani Subramanian and colleagues note ...
(Date:7/30/2014)... Los Angeles, CA (PRWEB) July 30, 2014 ... Ghasri, now offers comprehensive cosmetic dental treatments that can ... office, Sunset Plaza Dental. Healthy teeth and gums form ... affect a person’s smile. While minor chips, misshapen teeth ... can all detract from a smile’s appearance. The right ...
(Date:7/30/2014)... 2014 All the children at Father’s ... rejection, abuse and exploitation tend to mar their respective ... and dejection. Quality youth development has underpinnings in a ... boosts confidence and in the foreseeable future, would assist ... light that the mere presence of Foundation members in ...
(Date:7/30/2014)... WEDNESDAY, July 30, 2014 (HealthDay News) -- ,Middle-aged adults ... twice as likely as others to develop severe memory ... The British researchers said their findings could help ... might benefit from help for problem drinking. "We ... and levels of current alcohol consumption -- that understanding ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 We know pregnancy ... to peanut butter and ice cream—but the latest episode of ... MDs , just posted online, has a recipe that is ... a James Beard Award-winning chef serves up an easy recipe ... is the executive chef at Rasika, which was named one ...
Breaking Medicine News(10 mins):Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, Now Offers Comprehensive Cosmetic Dental Treatments 2Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, Now Offers Comprehensive Cosmetic Dental Treatments 3Health News:The Edusei Foundation Donates Food and Assorted Items to the Fathers’ Home Care Ministries in Takoradi, Ghana 2Health News:Adults Who've Abused Alcohol May Be at Risk for Memory Problems 2Health News:What to Eat When You’re Expecting 2
... Duke University Medical Center researchers, African-Americans have a notably ... hepatitis C than non-Hispanic whites. ,The ... which is the journal for the members of the ... with hepatitis C (HCV) infections experience a reduced response ...
... A new study published in the Journal of Neurology, Neurosurgery ... during //two peak periods. Japanese researchers who conducted the study ... and 8am and 6pm and 8pm. ,The researchers examined ... was lowest during sleep. This may probably be due to ...
... Health Service Executive in Ireland is all set to offer ... overcrowding.// ,The Irish Examiner reports that hospitals may be ... the A&E crisis, where patients are made to wait for ... patients are not made to wait over 24 hours. Also ...
... University of Siena, researchers found that cartoons are twice as ... medical procedures, such as having a blood sample taken. ... Scatte Clinic divided 69 children, aged between 7 and 12, ... kids started watching TV cartoons at least two minutes before ...
... a little extra income can make a big difference in helping ... the upper end," said Meredith Minkler, an author of a report ... England Journal of Medicine. "We always knew there was a major ... that the middle class was at a substantial disadvantage to slightly ...
... west of Scotland; Inverclyde, is to be revamped.// ... and increase in the range of community-based services will ... ,An already existing ward at Inverclyde Royal Hospital ... Children's hospital services, therapy services currently provided by ...
Cached Medicine News:Health News:African-Americans Have A Reduced Response To Hepatitis C Treatment 2Health News:African-Americans Have A Reduced Response To Hepatitis C Treatment 3Health News:The higher the income the lower the disability rates! 2Health News:A new deal for childcare services given go-ahead 2
... is a primary component of an integrated ... sampling, and slide preparation all strictly ... LBP Processor produces high-quality sample slides featuring ... of cytology specimen types. It processes 40 ...
... offer a safe alternative to using positive ... applications such as PCR(a), pipetting radioactive materials ... are excellent for tissue culture, gel loading, ... prevent aerosol contaminants and liquids from reaching ...
... Packed conveniently in plastic-wrapped racks of ... to useno need to autoclave. Sterilized Diamond ... efficient sterilization and are delivered with a ... irradiation. Sterilized Diamond Tips are certified free ...
... been designed to optimize the accuracy and ... tip products is widely recognized by customers ... been extended over the years and now ... special tips including filter tips, certified pure ...
Medicine Products: